# Prevention of Irinotecan Induced Diarrhea by Probiotics

> **NCT01410955** · PHASE3 · COMPLETED · sponsor: **Monsea Ltd.** · enrollment: 46 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic formula
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01410955
- **Lead sponsor:** Monsea Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-12
- **Final completion:** 2014-01
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2014-01-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01410955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01410955, "Prevention of Irinotecan Induced Diarrhea by Probiotics". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01410955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*